New drug targets hidden hormone problem to boost heart and bone health
NCT ID NCT07247058
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether the drug Isturisa can improve blood sugar, cholesterol, blood pressure, weight, and bone strength in people with mild autonomous cortisol secretion (MACS), a condition where the body makes too much cortisol. Ten adults with MACS will take Isturisa for two years and have regular check-ups. The goal is to see if the drug can reduce the health risks linked to this hormone imbalance.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MILD AUTONOMOUS CORTISOL SECRETION (MACS) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Johns Hopkins University School of Medicine
RECRUITINGBaltimore, Maryland, 21205, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a drug tame excess cortisol in a common hormone disorder?
- Can a diabetes drug fix lingering health issues after adrenal surgery?
- Can a diabetes drug replace surgery for a rare hormone disorder?
- Researchers hunt for best test to spot hidden hormone problem in adrenal tumors
- Drug showdown: which pill tames cortisol better?
- Can a drug tame excess cortisol? new trial tests metyrapone